|
|
 Previous Article | Table of Contents | Next Article 
Inhibition of human immunodeficiency virus-1 (HIV-1) replication after
transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells
from HIV-1-infected donors using retroviral vectors containing anti-HIV-1
genes
G Bauer, P Valdez, K Kearns, I Bahner, SF Wen, JA Zaia and DB Kohn
Department of Pediatrics, University of Southern California School of
Medicine, Los Angeles, USA.
Transfer of "anti-HIV-1 genes" into hematopoietic stem cells of human
immunodeficiency virus-1 (HIV-1)-infected individuals may be a potent
therapeutic approach to render mature cells arising from transduced stem
cells resistant to the destructive events associated with HIV-1 infection.
To determine the feasibility of gene therapy for acquired immunodeficiency
syndrome in individuals already infected with HIV-1, granulocyte
colony-stimulating factor mobilized peripheral blood CD34+ cells were
isolated from HIV-1-infected individuals and transduced with retroviral
vectors containing three different anti-HIV-1-genes: the Rev binding domain
of the Rev Responsive Element (RRE decoy) (L-RRE-neo), a double hammerhead
ribozyme vector targeted to cleave the tat and rev transcripts
(L-TR/TAT-neo), and the trans-dominant mutant of rev (M10) (L-M10-SN). As a
control, a vector mediating only neomycin resistance (LN) was used. After 3
days of transduction on allogeneic stroma in the presence of stem cell
factor, interleukin-6 (IL-6), and IL-3, the cultures were G418-selected,
and then challenged with HIV-1(JR-FL) and a primary HIV-1 isolate. Compared
with the control cultures, the L-RRE- neo-, L-TR/TAT-neo-, and
L-M10-SN-transduced cultures displayed up to 1,000-fold inhibition of HIV-1
replication after challenge with HIV- 1(JR-FL) and the primary HIV-1
isolate. Growth of the hematopoietic cells in long-term bone marrow culture
was not perturbed by the presence of any of the anti-HIV-1 genes. This
study shows that anti-HIV- 1 genes can be introduced into CD34+ cells from
individuals already infected with HIV-1, and strongly inhibit HIV-1
replication in primary monocytes derived from the CD34+ progenitors.
Volume 89,
Issue 7,
pp. 2259-2267,
04/01/1997
Copyright © 1997 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Santat, H. Paz, C. Wong, L. Li, J. Macer, S. Forman, K. K. Wong, and S. Chatterjee
Recombinant AAV2 transduction of primitive human hematopoietic stem cells capable of serial engraftment in immune-deficient mice
PNAS,
August 2, 2005;
102(31):
11053 - 11058.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. V. Morris, R. A. Grahn, D. J. Looney, and N. C. Pedersen
Characterization of a mobilization-competent simian immunodeficiency virus (SIV) vector containing a ribozyme against SIV polymerase
J. Gen. Virol.,
June 1, 2004;
85(6):
1489 - 1496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Egelhofer, G. Brandenburg, H. Martinius, P. Schult-Dietrich, G. Melikyan, R. Kunert, C. Baum, I. Choi, A. Alexandrov, and D. von Laer
Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides
J. Virol.,
January 15, 2004;
78(2):
568 - 575.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. S. Fisher, P. Joshi, and V. R. Prasad
Mutations That Confer Resistance to Template-Analog Inhibitors of Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Lead to Severe Defects in HIV Replication
J. Virol.,
March 19, 2002;
76(8):
4068 - 4072.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Mautino, N. Keiser, and R. A. Morgan
Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Replication by HIV-1-Based Lentivirus Vectors Expressing Transdominant Rev
J. Virol.,
April 15, 2001;
75(8):
3590 - 3599.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. M. Levine, D. T. Scadden, J. A. Zaia, and A. Krishnan
Hematologic Aspects of HIV/AIDS
Hematology,
January 1, 2001;
2001(1):
463 - 478.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. B. Campbell, A. Sevin, R. W. Coombs, G. C. Peterson, M. Rosandich, D. R. Kuritzkes, J. Mladenovic, A. Landay, R. Wong, D. Ambruso, et al.
Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells
Blood,
January 1, 2000;
95(1):
48 - 55.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Andang, J. Hinkula, G. Hotchkiss, S. Larsson, S. Britton, F. Wong-Staal, B. Wahren, and L. Ahrlund-Richter
Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model
PNAS,
October 26, 1999;
96(22):
12749 - 12753.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Kohn, G. Bauer, C. R. Rice, J.C. Rothschild, D. A. Carbonaro, P. Valdez, Q.-l. Hao, C. Zhou, I. Bahner, K. Kearns, et al.
A Clinical Trial of Retroviral-Mediated Transfer of a rev-Responsive Element Decoy Gene Into CD34+ Cells From the Bone Marrow of Human Immunodeficiency Virus-1-Infected Children
Blood,
July 1, 1999;
94(1):
368 - 371.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. A. James and I. Gibson
The Therapeutic Potential of Ribozymes
Blood,
January 15, 1998;
91(2):
371 - 382.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Junker, J. J. Moon, C. S. Kalfoglou, I. Sniecinski, S. J. Forman, J. A. Zaia, H. Kaneshima, and E. Bohnlein
Hematopoietic Potential and Retroviral Transduction of CD34+Thy-1+ Peripheral Blood Stem Cells From Asymptomatic Human Immunodeficiency Virus Type-1-Infected Individuals Mobilized With Granulocyte Colony-Stimulating Factor
Blood,
June 15, 1997;
89(12):
4299 - 4306.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
